Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) TrialClinical Perspective

Autor: Azizi, Michel, Pereira, Helena, Hamdidouche, Idir, Gosse, Philippe, Monge, Matthieu, Bobrie, Guillaume, Delsart, Pascal, Mounier-Vehier, Claire, Courand, Pierre-Yves, Lantelme, Pierre, Denolle, Thierry, Dourmap-Collas, Caroline, Girerd, Xavier, Michel Halimi, Jean, Zannad, Faiez, Ormezzano, Olivier, Vaisse, Bernard, Herpin, Daniel, Ribstein, Jean, Chamontin, Bernard, Mourad, Jean-Jacques, Ferrari, Emile, Plouin, Pierre-Francois, Jullien, Vincent, Sapoval, Marc, Chatellier, Gilles, Investigators, DENERHTN

Publikováno v: Circulation
Circulation, American Heart Association, 2016, 134 (12), pp.847-857. ⟨10.1161/CIRCULATIONAHA.116.022922⟩
Circulation, 2016, 134 (12), pp.847-857. ⟨10.1161/CIRCULATIONAHA.116.022922⟩

International audience; BACKGROUND:The DENERHTN trial (Renal Denervation for Hypertension) confirmed the blood pressure-lowering efficacy of renal denervation added to a standardized stepped-care antihypertensive treatment for resistant hypertension

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7472ab30106287b944f5381e96eb8738
https://hal.archives-ouvertes.fr/hal-01824916